Intricate technical design of the Soldier Balloon Occlusion Microcatheter allows for easy navigation through small complex vascular structures providing enhanced reach to distal target sites.

 

*Soldier is only available in Europe with additional availability coming 2022!

Designing Performance. Delivering Precision.

Soldier Product Family

Designed for arterial embolization procedures such as:

  • Transarterial Embolization (TAE)
  • Transarterial Chemoembolization (TACE)
  • Radioembolization (Y-90)
  • Arteriovenous Malformation (AVM)
  • Prostate Artery Embolization (PAE)
  • Gastrointestinal Bleeds
  • Renal Angiomyolipoma (AML)
  • Uterine Fibroid Embolization (UFE)

Compatible with the delivery of *:

  • Lipiodol®
  • Glue (n-bCA)
  • Coils up to 0.018″
  • Gelfoam
  • Spherical particles up to 900 μm
  • Dimethyl Sulfoxide (DMSO)
  • Ethanol (EtOH)

*See Sniper Chemical Compatibility Statement Letter MK-0351 below. Embolx does not make any claims; for information purposes only. 

  1. Rose S, Halstead G, Narsinh K. Pressure-Directed Embolization of Hepatic Arteries in a Porcine Model Using a Temporary Occlusion Balloon Microcatheter: Proof of Concept. Cardiovasc Intervent Radiol (2017) 40: 1769.
  2. Isaacson A, Hartman T, Bagla S, Burke C. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization. J Vasc Interv Radiol (2018) 29: 85-89.
  3. Maruyama M, Yoshizako T, Nakamura T, et al. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol (2016) 39: 359-366.
  4. Irie T, Kuramochi M, Takahashi N. Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodules during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure. Cariovasc Intervent Radiol (2013) 36: 706-713.
  5. Ogawa M, Takayasu K, Hirayama M, et al. Efficacy of a microballoon catheter in transarterial chemoembolization using miriplatin, a lipophilic anticancer drug: short-term results. Hepatology Research (2016) 46: E60-69.
  6. Arai H, Abe T, Takayama H, et al. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatology Research (2015) 45: 663-666.
  7. Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatology Research (2016) 46: 209-214.
  8. Stephan Ogenstad, Statogen Consulting LLC. Meta-analysis of clinical studies performed by: Ogawa (2016) ref. 5, Arai (2015) ref. 6, and Irie (2016) ref. 7. Analysis on file at Embolx, Inc. (2017).